[go: up one dir, main page]

PL441645A1 - Sposób odróżniania złośliwych i łagodnych guzków tarczycy - Google Patents

Sposób odróżniania złośliwych i łagodnych guzków tarczycy

Info

Publication number
PL441645A1
PL441645A1 PL441645A PL44164522A PL441645A1 PL 441645 A1 PL441645 A1 PL 441645A1 PL 441645 A PL441645 A PL 441645A PL 44164522 A PL44164522 A PL 44164522A PL 441645 A1 PL441645 A1 PL 441645A1
Authority
PL
Poland
Prior art keywords
thyroid nodule
malignant thyroid
differentiating benign
genes
thyroid
Prior art date
Application number
PL441645A
Other languages
English (en)
Inventor
Jolanta Krajewska
Alicja Płuciennik
Małgorzata OCZKO-WOJCIECHOWSKA
Aleksander Płaczek
Michał JARZĄB
Sebastian Student
Agata Wilk
Agnieszka Czarniecka
Aleksandra Pfeifer
Agnieszka Kotecka-Blicharz
Krzysztof Łakomiec
Ewa Chmielik
Dorota Słowińska-Klencka
Marek Dedejcus
Barbara JARZĄB
Krzysztof Fujarewicz
Original Assignee
Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie-Państwowy Instytut Badawczy Oddział W Gliwicach
Politechnika Śląska
Polskie Towarzystwo Endokrynologiczne
Uniwersytet Medyczny w Łodzi
Wasko Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie-Państwowy Instytut Badawczy Oddział W Gliwicach, Politechnika Śląska, Polskie Towarzystwo Endokrynologiczne, Uniwersytet Medyczny w Łodzi, Wasko Spółka Akcyjna filed Critical Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie-Państwowy Instytut Badawczy Oddział W Gliwicach
Priority to PL441645A priority Critical patent/PL441645A1/pl
Publication of PL441645A1 publication Critical patent/PL441645A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób różnicowania łagodnych i złośliwych guzków tarczycy w próbce z biopsji, sklasyfikowanej zgodnie z systemem Bethesda, który obejmuje etapy izolacji RNA oraz określenie poziomu ekspresji znormalizowanego zestawu genów, zawierającego geny takie jak AMOT, DCSTAMP, NOD1, SLC26A7, EMP2, EGR1, MPZL2, ITGA2, MET, SLPI, TPO. Do różnicowania guzków tarczycy wykorzystuje się algorytm klasyfikatora, który nauczony jest na danych ekspresji genów skorelowanych z charakterem guzka tarczycy. Ponadto ustala się prawdopodobieństwo złośliwości badanej próbki.
PL441645A 2022-07-05 2022-07-05 Sposób odróżniania złośliwych i łagodnych guzków tarczycy PL441645A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL441645A PL441645A1 (pl) 2022-07-05 2022-07-05 Sposób odróżniania złośliwych i łagodnych guzków tarczycy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL441645A PL441645A1 (pl) 2022-07-05 2022-07-05 Sposób odróżniania złośliwych i łagodnych guzków tarczycy

Publications (1)

Publication Number Publication Date
PL441645A1 true PL441645A1 (pl) 2024-01-08

Family

ID=89473649

Family Applications (1)

Application Number Title Priority Date Filing Date
PL441645A PL441645A1 (pl) 2022-07-05 2022-07-05 Sposób odróżniania złośliwych i łagodnych guzków tarczycy

Country Status (1)

Country Link
PL (1) PL441645A1 (pl)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2569626A2 (en) * 2010-05-11 2013-03-20 Veracyte, Inc. Methods and compositions for diagnosing conditions
WO2013138726A1 (en) * 2012-03-15 2013-09-19 Sabiosciences Corp. Thyroid cancer biomarker
US20170329894A1 (en) * 2008-11-17 2017-11-16 Veracyte, Inc. Algorithms for disease diagnostics
EP3467123A2 (en) * 2008-11-17 2019-04-10 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170329894A1 (en) * 2008-11-17 2017-11-16 Veracyte, Inc. Algorithms for disease diagnostics
EP3467123A2 (en) * 2008-11-17 2019-04-10 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
EP2569626A2 (en) * 2010-05-11 2013-03-20 Veracyte, Inc. Methods and compositions for diagnosing conditions
WO2013138726A1 (en) * 2012-03-15 2013-09-19 Sabiosciences Corp. Thyroid cancer biomarker

Similar Documents

Publication Publication Date Title
Lyra et al. Meeting the challenge of DNA barcoding Neotropical amphibians: polymerase chain reaction optimization and new COI primers
Wang et al. A new scheme for strain typing of methicillin-resistant Staphylococcus aureus on the basis of matrix-assisted laser desorption ionization time-of-flight mass spectrometry by using machine learning approach
Taib et al. Phylogenetic affiliation of SSU rRNA genes generated by massively parallel sequencing: new insights into the freshwater protist diversity
Pawlowski et al. Eukaryotic richness in the abyss: insights from pyrotag sequencing
Nilsson et al. Five simple guidelines for establishing basic authenticity and reliability of newly generated fungal ITS sequences
CN104573410A (zh) 基于分子子网与随机森林分类器的癌症化疗敏感性预测方法
Brikun et al. A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
CN105808709A (zh) 人脸识别快速检索方法及装置
CN106384050B (zh) 一种基于最大频繁子图挖掘的动态污点分析方法
CN112779334B (zh) 一种用于前列腺癌早期筛查的甲基化标志物组合及筛选方法
CN109830264B (zh) 肿瘤患者基于甲基化位点进行分类的方法
Joiner et al. Pax2 expression in simultaneously diagnosed WHO and EIN classification systems
WO2024066461A1 (zh) 基于宏基因组和宏转录组识别油藏驱油功能微生物的方法
Ke et al. Identifying patch-level MSI from histological images of colorectal cancer by a knowledge distillation model
PL441645A1 (pl) Sposób odróżniania złośliwych i łagodnych guzków tarczycy
CN113584175A (zh) 一组评估肾乳头状细胞癌进展风险的分子标记及其筛选方法和应用
Wang et al. Large-scale application of palaeoproteomics (Zooarchaeology by Mass Spectrometry; ZooMS) in two Palaeolithic faunal assemblages from China
Osama et al. Gene selection and tumor identification based on a hybrid of the multi-filter embedded recursive mountain gazelle algorithm
SANTANA-SANTOS et al. Accurate identification of primary site in tumors of unknown origin (TUO) using DNA methylation
Gonçalves-Reis et al. Analytical validation and algorithm improvement of HepatoPredict kit to assess hepatocellular carcinoma prognosis before a liver transplantation
CN116930495A (zh) 一种基于单细胞测序的肝癌标志物及其应用
CN104573027B (zh) 一种从文档集中挖掘特征词的系统和方法
PL441643A1 (pl) Sposób różnicowania łagodnych i złośliwych guzków tarczycy
Wilk et al. On Stability of Feature Selection Based on MALDI Mass Spectrometry Imaging Data and Simulated Biopsy
Deng et al. GeneLLM: A large cfRNA language model for cancer screening from raw reads